Literature DB >> 9764632

The physician's role in women's decision making about hormone replacement therapy.

K M Newton1, A Z Lacroix, S G Leveille, C Rutter, N L Keenan, L A Anderson.   

Abstract

OBJECTIVE: To ascertain the sources of information women use when making decisions about hormone replacement therapy (HRT).
METHODS: A cross-sectional, population-based computer-assisted telephone survey of 1082 randomly selected women aged 50-80 years (80.3% response rate) was conducted at Group Health Cooperative of Puget Sound, a large staff-model health maintenance organization in Washington state.
RESULTS: Overall, 460 participants (42.5%) were current HRT users, 226 (20.9%) were past users, and 396 (36.6%) were never users. Discussions with physicians dominated as the major source of information used in decision making by current (83.4%) and past (65.5%) users, but were less often cited by never users (44.4%); printed material was used by 44.5% of women. Although 72.1% of current users reported that the amount of information received from their physician about the benefits of HRT was about right, only 48.2% of past users and 33.6% of never users shared this view (P < .001 current versus never), and 13.3% of current users, 32.6% of past users and 58% of never users reported receiving no information from their physician about HRT's benefits.
CONCLUSION: Hormone replacement therapy use is strongly related to interactions between women and their physicians. Many women use written materials to make decisions about HRT. A large proportion of women feel inadequately informed about HRT's risks and benefits. Much work remains to be accomplished toward meeting the goal of the US Preventive Services Task Force that all perimenopausal and postmenopausal women be counseled about the potential benefits and risks of HRT.

Entities:  

Mesh:

Year:  1998        PMID: 9764632     DOI: 10.1016/s0029-7844(98)00272-5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  9 in total

1.  Climacteric Complaints after Breast Cancer - Is HRT an Option?

Authors:  Christian F Singer
Journal:  Breast Care (Basel)       Date:  2008-06-20       Impact factor: 2.860

2.  Hormone therapy discontinuation: physician practices after the Women's Health Initiative.

Authors:  Katherine M Newton; Susan D Reed; Louis C Grothaus; Andrea Z La Croix; Larissa Nekhlyudov; Kelly Ehrlich; Evette J Ludman
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

3.  Factors associated with successful discontinuation of hormone therapy.

Authors:  Katherine M Newton; Susan D Reed; Larissa Nekhyludov; Louis C Grothaus; Evette J Ludman; Kelly Ehrlich; Andrea Z LaCroix
Journal:  J Womens Health (Larchmt)       Date:  2014-01-20       Impact factor: 2.681

4.  Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump.

Authors:  Rebecca Taylor; Kenneth Taguchi
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.166

Review 5.  Treating osteoporosis with bisphosphonates and addressing adherence: a review of oral ibandronate.

Authors:  Charles H Chesnut
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Prevalence of and factors associated with hormone replacement therapy counseling: results from the 1994 National Health Interview Survey.

Authors:  P Zhang; G Tao; L A Anderson
Journal:  Am J Public Health       Date:  1999-10       Impact factor: 9.308

7.  Changes in newspaper coverage about hormone therapy with the release of new medical evidence.

Authors:  Jennifer S Haas; Berta Geller; Diana L Miglioretti; Diana S M Buist; David E Nelson; Karla Kerlikowske; Patricia A Carney; Erica S Breslau; Sarah Dash; Mary K Canales; Rachel Ballard-Barbash
Journal:  J Gen Intern Med       Date:  2006-02-22       Impact factor: 5.128

8.  Average household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy use.

Authors:  Jennifer S Haas; Diana L Miglioretti; Berta Geller; Diana S M Buist; David E Nelson; Karla Kerlikowske; Patricia A Carney; Sarah Dash; Erica S Breslau; Rachel Ballard-Barbash
Journal:  J Gen Intern Med       Date:  2007-01       Impact factor: 5.128

9.  Efficacy of yoga for vasomotor symptoms: a randomized controlled trial.

Authors:  Katherine M Newton; Susan D Reed; Katherine A Guthrie; Karen J Sherman; Cathryn Booth-LaForce; Bette Caan; Barbara Sternfeld; Janet S Carpenter; Lee A Learman; Ellen W Freeman; Lee S Cohen; Hadine Joffe; Garnet L Anderson; Joseph C Larson; Julie R Hunt; Kristine E Ensrud; Andrea Z LaCroix
Journal:  Menopause       Date:  2014-04       Impact factor: 3.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.